Gene · 554213
Papers1,524
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,524
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Profile analysis of differentially expressed long non‑coding RNAs in metabolic memory induced by high glucose in human umbilical vein endothelial cells. | Exp Ther Med | 2023 | 37206566 | PubTator, text mining | PubMed |
| MicroRNA, mRNA, and Proteomics Biomarkers and Therapeutic Targets for Improving Lung Cancer Treatment Outcomes. | Cancers (Basel) | 2023 | 37190222 | PubTator, text mining | PubMed |
| Exosomes and circular RNAs: promising partners in hepatocellular carcinoma from bench to bedside. | Discov Oncol | 2023 | 37154831 | PubTator, text mining | PubMed |
| The molecular mechanisms in prenatal drug exposure-induced fetal programmed adult cardiovascular disease. | Front Pharmacol | 2023 | 37153765 | PubTator, text mining | PubMed |
| Genome-wide CRISPR/Cas9 screening identifies a targetable MEST-PURA interaction in cancer metastasis. | EBioMedicine | 2023 | 37149929 | PubTator, text mining | PubMed |
| A local translation program regulates centriole amplification in the airway epithelium. | Sci Rep | 2023 | 37127654 | PubTator, text mining | PubMed |
| Circular RNAs: pivotal role in the leukemogenesis and novel indicators for the diagnosis and prognosis of acute myeloid leukemia. | Front Oncol | 2023 | 37124518 | PubTator, text mining | PubMed |
| New progress in the role of microRNAs in the diagnosis and prognosis of triple negative breast cancer. | Front Mol Biosci | 2023 | 37122564 | PubTator, text mining | PubMed |
| Identification of biomarkers, pathways, and potential therapeutic targets for heart failure using next-generation sequencing data and bioinformatics analysis. | Ther Adv Cardiovasc Dis | 2023 | 37092838 | PubTator, text mining | PubMed |
| Challenges of EGFR-TKIs in NSCLC and the potential role of herbs and active compounds: From mechanism to clinical practice. | Front Pharmacol | 2023 | 37089959 | PubTator, text mining | PubMed |
| Landscape of NcRNAs involved in drug resistance of breast cancer. | Clin Transl Oncol | 2023 | 37067729 | PubTator, text mining | PubMed |
| CircRNA: A new class of targets for gastric cancer drug resistance therapy. | Pathol Oncol Res | 2023 | 37065861 | PubTator, text mining | PubMed |
| Quadra-Stable Dynamics of p53 and PTEN in the DNA Damage Response. | Cells | 2023 | 37048159 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs (lncRNAs) as Regulators of the PI3K/AKT/mTOR Pathway in Gastric Carcinoma. | Int J Mol Sci | 2023 | 37047267 | PubTator, text mining | PubMed |
| Non-Coding RNAs Derived from Extracellular Vesicles Promote Pre-Metastatic Niche Formation and Tumor Distant Metastasis. | Cancers (Basel) | 2023 | 37046819 | PubTator, text mining | PubMed |
| Empowering the Potential of CAR-T Cell Immunotherapies by Epigenetic Reprogramming. | Cancers (Basel) | 2023 | 37046597 | PubTator, text mining | PubMed |
| RNA landscapes of brain tissue and brain tissue-derived extracellular vesicles in simian immunodeficiency virus (SIV) infection and SIV-related central nervous system pathology. | bioRxiv | 2023 | 37034720 | PubTator, text mining | PubMed |
| Exosomes and osteosarcoma drug resistance. | Front Oncol | 2023 | 37007086 | PubTator, text mining | PubMed |
| Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern? | PLoS Pathog | 2023 | 36996026 | PubTator, text mining | PubMed |
| Using Small Non-Coding RNAs in Extracellular Vesicles of Semen as Biomarkers of Male Reproductive System Health: Opportunities and Challenges. | Int J Mol Sci | 2023 | 36982521 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554213/papers?page=8